Industry Leader’s Keynote Panel Discussion: Targeting Infectious Diseases – What is the Strategy?

Time: 10:00 am
day: Day One


  • The COVID-19 pandemic has led to a resurgence of investment in the infectious disease field, but why has T-cell immunity become so important?
  • This panel will address the industry leader’s thoughts on the opportunity for targeting infectious diseases like SARS-CoV-2 and HIV, the strategy to identify immunogenic targets, safety concerns with increasing inflammation, and future plans to target more infectious diseases